NYSE:SNN Smith & Nephew (SNN) Stock Price, News & Analysis $28.83 +0.22 (+0.78%) Closing price 03:59 PM EasternExtended Trading$28.76 -0.08 (-0.27%) As of 04:25 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Stock Analysis Stock AnalysisAnalyst ForecastsChartCompetitorsDividendFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock About Smith & Nephew Stock (NYSE:SNN) 30 days 90 days 365 days Advanced Chart View Price History Chart DataSkip Price History Chart Get Smith & Nephew alerts:Sign Up Key Stats Today's Range$28.66▼$28.9650-Day Range$24.91▼$29.3852-Week Range$23.69▼$31.72Volume411,219 shsAverage Volume795,367 shsMarket Capitalization$12.63 billionP/E Ratio13.35Dividend Yield3.09%Price Target$28.00Consensus RatingHold Company OverviewSmith & Nephew plc engages in the development, manufacture, marketing, and sale of medical devices. It operates through the following segments: Orthopaedics, Sports Medicine and ENT, and Advanced Wound Management. The Orthopaedics and Sports Medicine and ENT segment consists of the following businesses: knee implants, hip implants, other reconstruction, trauma, sports medicine joint repair, arthroscopic enabling technologies, and ENT. The Advanced Wound Management segment includes advanced wound care, advanced wound bioactives, and advanced wound devices businesses. The company was founded in 1856 and is headquartered in Watford, the United Kingdom.Read More… Smith & Nephew Stock Analysis - MarketRank™See Top-Rated MarketRank™ Stocks50th Percentile Overall ScoreSNN MarketRank™: Smith & Nephew scored higher than 50% of companies evaluated by MarketBeat, and ranked 571st out of 933 stocks in the medical sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation. Analyst's Opinion1.0 / 5Analyst RatingHold Consensus RatingSmith & Nephew has received a consensus rating of Hold. The company's average rating score is 2.00, and is based on no buy ratings, 6 hold ratings, and no sell ratings.Amount of Analyst CoverageSmith & Nephew has only been the subject of 4 research reports in the past 90 days.Read more about Smith & Nephew's stock forecast and price target. Earnings and Valuation3.1 / 5Proj. Earnings Growth18.34% Earnings GrowthEarnings for Smith & Nephew are expected to grow by 18.34% in the coming year, from $1.69 to $2.00 per share.Price to Earnings Ratio vs. the MarketThe P/E ratio of Smith & Nephew is 13.35, which means that it is trading at a less expensive P/E ratio than the market average P/E ratio of about 24.31.Price to Earnings Ratio vs. SectorThe P/E ratio of Smith & Nephew is 13.35, which means that it is trading at a less expensive P/E ratio than the Medical sector average P/E ratio of about 26.99.Price to Earnings Growth RatioSmith & Nephew has a PEG Ratio of 1.26. PEG Ratios above 1 indicate that a company could be overvalued.Price to Book Value per Share RatioSmith & Nephew has a P/B Ratio of 2.41. P/B Ratios below 3 indicates that a company is reasonably valued with respect to its assets and liabilities.Read more about Smith & Nephew's valuation and earnings. Short Interest3.0 / 5Short Interest LevelHealthy Percentage of Shares Shorted0.43% of the float of Smith & Nephew has been sold short.Short Interest Ratio / Days to CoverSmith & Nephew has a short interest ratio ("days to cover") of 2.2, which is generally considered an acceptable ratio of short interest to trading volume.Change versus previous monthShort interest in Smith & Nephew has recently increased by 22.88%, indicating that investor sentiment is decreasing significantly. Dividend2.5 / 5Dividend StrengthModerate Dividend YieldSmith & Nephew pays a meaningful dividend of 3.15%, higher than the bottom 25% of all stocks that pay dividends.Dividend GrowthSmith & Nephew does not have a long track record of dividend growth.Dividend CoverageThe dividend payout ratio of Smith & Nephew is 41.20%. This payout ratio is at a healthy, sustainable level, below 75%.Dividend SustainabilityBased on earnings estimates, Smith & Nephew will have a dividend payout ratio of 44.50% next year. This indicates that Smith & Nephew will be able to sustain or increase its dividend.Read more about Smith & Nephew's dividend. Sustainability and ESGN/AEnvironmental ScoreN/A Percentage of Shares Shorted0.43% of the float of Smith & Nephew has been sold short.Short Interest Ratio / Days to CoverSmith & Nephew has a short interest ratio ("days to cover") of 2.2, which is generally considered an acceptable ratio of short interest to trading volume.Change versus previous monthShort interest in Smith & Nephew has recently increased by 22.88%, indicating that investor sentiment is decreasing significantly. News and Social Media3.9 / 5News Sentiment1.08 News SentimentSmith & Nephew has a news sentiment score of 1.08. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a higher news sentiment than the 0.87 average news sentiment score of Medical companies.News Coverage This WeekMarketBeat has tracked 7 news articles for Smith & Nephew this week, compared to 3 articles on an average week.Search Interest1 people have searched for SNN on MarketBeat in the last 30 days. MarketBeat Follows1 people have added Smith & Nephew to their MarketBeat watchlist in the last 30 days. Company Ownership0.0 / 5Insider TradingN/A Insider Buying vs. Insider SellingIn the past three months, Smith & Nephew insiders have not sold or bought any company stock.Percentage Held by InsidersOnly 1.00% of the stock of Smith & Nephew is held by insiders.Percentage Held by InstitutionsOnly 25.64% of the stock of Smith & Nephew is held by institutions.Read more about Smith & Nephew's insider trading history. Receive SNN Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Smith & Nephew and its competitors with MarketBeat's FREE daily newsletter. Email Address SNN Stock News HeadlinesSmith+Nephew awarded contract to provide Negative Pressure Wound Therapy systems to the United States Department of DefenseMay 27 at 10:00 AM | globenewswire.comSmith & Nephew plc (NYSE:SNN) Receives $28.00 Average PT from AnalystsMay 23, 2025 | americanbankingnews.comA grave, grave error.I thought what happened 25 years ago was a once- in-a-lifetime event… but how wrong I was. Because here we are, a quarter of a century later, almost to the exact day, and it’s happening again. May 29, 2025 | Porter & Company (Ad)Smith & Nephew's CARTIHEAL AGILI-C Cartilage Repair Implant Shows Significant Knee Pain ReliefMay 7, 2025 | finanznachrichten.deStudy shows patients treated with Smith+Nephew's CARTIHEAL™ AGILI-C™ Cartilage Repair Implant have an 87% lower relative risk of Total Knee Arthroplasty or Osteotomy at 4 years¹*May 7, 2025 | globenewswire.comSmith+Nephew to showcase its CORI™ Surgical System at surgical clinics across Germany, Austria and SwitzerlandMay 5, 2025 | globenewswire.comSmith & Nephew plc (SNN) Q1 2025 Earnings Call TranscriptMay 2, 2025 | seekingalpha.comLONDON BROKER RATINGS: HSBC cuts Smith & Nephew to 'hold'April 25, 2025 | lse.co.ukSee More Headlines SNN Stock Analysis - Frequently Asked Questions How have SNN shares performed this year? Smith & Nephew's stock was trading at $24.58 on January 1st, 2025. Since then, SNN stock has increased by 17.3% and is now trading at $28.8340. View the best growth stocks for 2025 here. How were Smith & Nephew's earnings last quarter? Smith & Nephew plc (NYSE:SNN) released its earnings results on Monday, November, 17th. The medical equipment provider reported $0.98 earnings per share (EPS) for the quarter, beating analysts' consensus estimates of $0.39 by $0.59. Who are Smith & Nephew's major shareholders? Top institutional shareholders of Smith & Nephew include Fiduciary Management Inc. WI (0.86%), Scharf Investments LLC (0.47%), Goldman Sachs Group Inc. (0.40%) and Armistice Capital LLC (0.40%). How do I buy shares of Smith & Nephew? Shares of SNN stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. What other stocks do shareholders of Smith & Nephew own? Based on aggregate information from My MarketBeat watchlists, some other companies that Smith & Nephew investors own include JPMorgan Chase & Co. (JPM), Johnson & Johnson (JNJ), PepsiCo (PEP), Taiwan Semiconductor Manufacturing (TSM), McDonald's (MCD), Sanofi (SNY) and Alibaba Group (BABA). Company Calendar Last Earnings11/17/2014Record date for 5/28 Dividend3/28/2025Ex-Dividend for 5/28 Dividend3/28/2025Dividend Payable5/28/2025Today5/29/2025Next Earnings (Estimated)8/05/2025Fiscal Year End12/31/2025Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeNYSE SectorMedical Industry Surgical appliances & supplies Sub-IndustryMedical Equipment Current SymbolNYSE:SNN CIK845982 Webwww.smith-nephew.com Phone441923477100Fax44-20-7930-3353Employees20,100Year Founded1856Price Target and Rating Average Stock Price Target$28.00 High Stock Price Target$28.00 Low Stock Price Target$28.00 Potential Upside/Downside-2.9%Consensus RatingHold Rating Score (0-4)2.00 Research Coverage6 Analysts Profitability EPS (Most Recent Fiscal Year)N/A Trailing P/E Ratio13.35 Forward P/E Ratio17.07 P/E Growth1.26Net IncomeN/A Net MarginsN/A Pretax MarginN/A Return on EquityN/A Return on AssetsN/A Debt Debt-to-Equity Ratio0.63 Current Ratio2.51 Quick Ratio1.11 Sales & Book Value Annual Sales$5.81 billion Price / Sales2.17 Cash Flow$3.61 per share Price / Cash Flow8.00 Book Value$11.94 per share Price / Book2.42Miscellaneous Outstanding Shares437,964,000Free Float432,826,000Market Cap$12.63 billion OptionableOptionable Beta0.68 Social Links Free Today: Your Guide to Smarter Options TradesLearn the basics of options trading and how to use them to boost returns and manage risk with this free report from MarketBeat. Click the link below to get your free copy.Get This Free Report This page (NYSE:SNN) was last updated on 5/29/2025 by MarketBeat.com Staff From Our PartnersWhite House to reset Social Security?Elon Musk's parting DOGE gift looks set to shock America... A single announcement by July 22nd could soon b...Altimetry | SponsoredA grave, grave error.I thought what happened 25 years ago was a once- in-a-lifetime event… but how wrong I was. Because here we...Porter & Company | SponsoredBuffett’s favorite chart just hit 209% – here’s what that means for goldA Historic Gold Announcement Is About to Rock Wall Street For months, sharp-eyed analysts have watched the ...Golden Portfolio | SponsoredTrump Exec Order 14179 is wealth “gift” to good Americans?Is President Trump’s Executive Order 14179… A secret way to restore wealth for good citizens? If you’ve ...Paradigm Press | SponsoredThis Signal Only Flashes Once Every 4 Years – And It Just TriggeredThis same signal has appeared twice before in the past 8 years — both times, it kicked off major moves in cryp...Crypto Swap Profits | Sponsored3..2..1.. AI 2.0 ignition (don’t sleep on this)I just put together an urgent new presentation that you need to see right away. In short: I believe we are...Timothy Sykes | SponsoredCollect $7k per month from Tesla’s SECRET dividendTesla doesn't pay a traditional dividend.... But I just discovered a secret backdoor to collect a secret 69...Investors Alley | SponsoredMan who predicted $100K Bitcoin sees a huge run coming for another coin …Sure enough, Bitcoin took off on the exact day Juan said it would. It's up more than 40% since the election...Weiss Ratings | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Smith & Nephew plc Please log in to your account or sign up in order to add this asset to your watchlist. Share Smith & Nephew With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.